Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMercantile Ports & Logistics Regulatory News (MPL)

Share Price Information for Mercantile Ports & Logistics (MPL)

Share Price is delayed by 15 minutes
Get Live Data
1.30    -0.25 (-16.13%)
Bid:
1.20
Ask:
1.40
Spread: 0.20 (16.667%)
Market Cap: £4.63m
MPL Live PriceLast checked at - London Stock Exchange

Intraday Mercantile Ports & Logistics Share Chart

Trading Update and Board Appointment

27 Feb 2025 07:00

RNS Number : 6155Y
Mercantile Ports & Logistics Ltd
27 February 2025
 

27 February 2025

 

Mercantile Ports & Logistics Limited

("MPL", the "Group" or the "Company")

 

Trading Update and Board Appointment

 

Mercantile Ports & Logistics (AIM:MPL), which is operating and continuing to develop a port and logistics facility in Navi Mumbai, Maharashtra, India provides the following update.

As reported in the Company's interim results in September last year, the Maharashtra State election had caused some contracts connected to major infrastructure projects in the region to pause, pending the outcome of the election. With the elections complete, the Company is pleased to report that the activity connected with these infrastructure projects has begun to flow again.

Shareholders will be aware that the Company has, for many months, been in discussions with its consortium of banks regarding the renegotiation of its loan facility. Whilst those discussions have continued to be constructive and Company continues to have the support of its banks and its major shareholder, Hunch Ventures, it has been a source of some frustration to the Board that they have taken so long. It is also clear that the period of time that has taken to conclude these discussions has had some negative impact on the Company's ability to secure longer term contracts with customers.

Taking these factors together, and whilst still being subject to audit, the Company expects to announce revenue for FY 2024 to be £4.6 million. However, the Company is pleased to announce that, with the support of Hunch Ventures, it is close to announcing a resolution to the debt position shortly and, in the meantime, continues to have the support of Hunch Ventures, with the loan facility provided by Hunch Ventures remaining undrawn.

The levels of enquiry to use the Facility are at record levels and the Company is confident that, following completion of the banking solution, the Company will return to the levels of growth that the Board had forecast.

At the same time, India is benefiting from some of the geo-political shifts that have taken place in recent months. The strategic positioning of the Facility (both geographically and financially) has attracted interest from parties in the US, who see investment and commercial opportunities at the Facility, particularly since the inauguration of the new US administration on 20 January 2025. In order to capitalise on these opportunities, the Company is delighted to announce that Stefan Passantino will be appointed as Non-Executive Director of the Company with immediate effect.

Mr Passantino has over 30 years of experience in election law, ethics, campaign finance, and lobbying, representing corporations, political figures, and advocacy groups. He has played a pivotal role in compliance and ethics programs, having served as Deputy Assistant to the President of the United States and Deputy White House Counsel, where he led the White House Compliance and Ethics programs during 2016-2018.

Mr Passantino currently represents leading national political committees, federal candidates, and advocacy groups. In the 2015-2016 election cycle, he advised prominent SuperPACs and advocacy groups, including those aligned with Ted Cruz, Rick Perry, Dr. Ben Carson, and the Trump Presidential Transition Team. He also co-chaired the Republican National Lawyers Association Ballot Access Project.

Notable clients include multinational corporations, tax-exempt advocacy groups, and political figures, such as Newt Gingrich, J. Dennis Hastert, Rick Perry, and several U.S. Senators and House Members. Mr Passantino serves as General Counsel to entities founded by Newt Gingrich and Kelly Loeffler and has over 20 years of experience providing ethics and lobbying training for Congress, the Administration, and corporations.

Mr Passantino is a co-author of Handbook on Corporate Political Activity: Emerging Corporate Governance Issues and a regular contributor to media outlets like CNN, POLITICO, and FOX News. As a Visiting Professor, he teaches campaign finance at Georgia State University College of Law and the University of Georgia.

Jeremy Warner Allen, Chair of the Board, commented: "I am delighted to welcome Stefan to the Board as Non-Executive Director. Stefan brings an impressive track record as a strategic adviser, complemented by extensive experience in corporate governance. As MPL looks to return to growth, I am excited to see how Stefan's experiences and contacts can help MPL to create value for shareholders."

 

Further disclosures required under the AIM Rules

In addition to his appointment to the MPL Board, Stefan Charles Passantino, aged 58, holds or has held the following directorships or partnerships in the past five years. Stefan currently holds no shares in the Company.

Current

Previous

Elections, LLC

The Gingrich Foundation, Inc.

KSV Investment Designs

 

 

For further information, please visit www.mercpl.com or contact:

MPL

c/o SEC Newgate

+44 (0) 20 3757 6880

Cavendish Capital Markets Limited

(Nomad and Broker)

Stephen Keys

+44 (0) 207 220 0500

SEC Newgate

(Financial Communications)

Bob Huxford

+44 (0) 20 3757 6880

mpl@newgatecomms.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDGGDDRUDDGUL
Date   Source Headline
13th May 20267:00 amRNSBoard Changes and Corporate Update
21st Apr 20268:54 amRNSUpdate re Karanja Asset
10th Apr 20264:23 pmRNSUpdate on Committee of Creditors' Meeting
9th Apr 20267:00 amRNSUpdate - Full Debt Redemption and Legal Action
10th Mar 20264:23 pmRNSDirector/PDMR Shareholding
10th Mar 20264:23 pmRNSDirector/PDMR Shareholding
2nd Feb 202610:00 amRNSDirector/PDMR Shareholding
18th Dec 20253:29 pmRNSUpdate on Ongoing Legal Proceedings
18th Dec 20253:29 pmRNSUpdate on Ongoing Legal Proceedings
17th Dec 20259:37 amRNSUpdate
15th Dec 202511:17 amRNSResult of General Meeting
19th Nov 20252:45 pmRNSNotice of GM and Related Party Transaction
19th Nov 20257:00 amRNSUpdate on Debt
11th Nov 202510:46 amRNSUpdate on Debt
8th Oct 20251:00 pmRNSUpdate on Delhi High Court Interim Order
30th Sep 20257:00 amRNSInterim Results
22nd Sep 20254:37 pmRNSUpdate re Loan Facility
19th Sep 202512:39 pmRNSUpdate re Loan Facility
8th Sep 20257:00 amRNSUpdate re Loan Facility
30th Jun 20257:00 amRNSFull Year Results
27th Feb 20257:00 amRNSTrading Update and Board Appointment
4th Oct 20243:30 pmRNSHolding(s) in Company
30th Sep 20247:00 amRNSInterim Results
12th Aug 20247:00 amRNSDirector/PDMR Shareholding
1st Jul 20249:30 amRNSHolding(s) in Company
27th Jun 20249:30 amRNSPublication of Annual Report
27th Jun 20247:01 amRNSFull Year Results
27th Jun 20247:00 amRNSRelated Party Transaction
13th Jun 20242:00 pmRNSHolding(s) in Company
15th Jan 20246:00 pmRNSDirector/PDMR Shareholding - Replacement
12th Jan 20247:00 amRNSDirector/PDMR Shareholding
10th Jan 20241:45 pmRNSDirector/PDMR Shareholding
10th Jan 20247:00 amRNSTrading Update
13th Dec 20237:00 amRNSChange of Nominated Adviser and Broker
24th Nov 20237:19 amRNSDirectorate Change
5th Oct 20233:00 pmRNSDirector/PDMR Shareholdings
29th Sep 20237:00 amRNSInterim Results
21st Aug 20238:02 amRNSHolding(s) in Company
4th Aug 20233:15 pmRNSHolding(s) in Company
2nd Aug 20237:00 amRNSHolding(s) in Company
28th Jul 20232:02 pmRNSResult of AGM & Issue of Equity
7th Jul 20233:06 pmRNSPublication of Circular and Notice of AGM
30th Jun 20239:05 amRNSHolding(s) in Company
29th Jun 20235:45 pmRNSPublication of Annual Report
29th Jun 20232:30 pmRNSFull Year Results
28th Jun 20234:59 pmRNSDirector/PDMR Shareholdings
27th Jun 20235:49 pmRNSSubscription
27th Jun 20233:56 pmRNSResult of General Meeting
13th Jun 20237:00 amRNSResult of Retail Offer
9th Jun 20237:00 amRNSResult of Placing and Subscription

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.